PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) [Rocket]

In millions, except per share items	Jun-30-23	Mar-31-23	Sep-30-22	Jun-30-22	Mar-31-22	Dec-31-21	Sep-30-21	Jun-30-21
	10-Q	10-Q	10-Q	10-Q	10-Q	8-K	10-Q	10-Q
Revenues:
Europe, Middle East and Africa	10.7	7.9		5.7	5.7
Consumable revenue	13.7	14.0		14.6	12.7
Instrument revenue	29.9	20.7		15.6	15.6
Asia-Pacific	12.9	12.0		8.0	8.4
Total revenues [+]	47.6	38.9	32.3	35.5	33.2	36.0	34.9	30.6
Products						31.2
Services						4.9
Revenue growth [+]	34.1%	17.3%	-7.4%	15.9%	14.4%	32.7%	82.8%	79.2%
Europe, Middle East and Africa	87.1%	38.1%
Consumable revenue	-5.7%	9.9%
Instrument revenue	91.6%	33.1%
Asia-Pacific	60.8%	42.5%
Americas	10.3%	-0.1%
Cost of goods sold [+]	32.0	29.1	3.2	19.3	19.0	19.3	4.0	16.9
Cost of product sales						14.9
Other cost of sales			3.0				3.9	3.6
Amortization of intangibles	0.2	0.2		0.2	0.2
Gross profit	15.5	9.8	29.1	16.2	14.2	16.8	30.9	13.8
Gross margin	32.7%	25.1%	90.1%	45.7%	42.7%	46.5%	88.6%	44.9%
Selling, general and administrative	40.6	39.8	88.2	39.3	39.8	37.3	89.8	51.3
Other selling, general and administrative
Research and development	46.2	48.9		50.3	52.9	42.6
Other operating expenses		-12.3				-0.2
EBITDA [+]	-68.1	-63.8		-70.9	-76.1	-62.9
EBITDA growth	-3.8%	-16.2%	0.2%	88.6%	125.7%	-381.6%	143.8%	59.7%
EBITDA margin	-143.2%	-163.9%	-182.8%	-199.8%	-229.4%	-174.8%	-169.0%	-122.7%
Depreciation	2.8	2.8		2.3	2.3
EBITA	-71.0	-66.5	-59.1	-73.2	-78.4	-62.9	-58.9	-37.6
EBITA margin	-149.2%	-171.0%	-182.8%	-206.3%	-236.2%	-174.8%	-169.0%	-122.7%
Amortization of intangibles	0.2	0.2		0.2	0.2	0.2
EBIT [+]	-71.2	-66.7	-59.1	-73.4	-78.6	-63.1	-58.9	-37.6
EBIT growth	-3.0%	-15.1%	0.2%	95.4%	133.1%	-382.5%	143.8%	59.7%
EBIT margin	-149.7%	-171.6%	-182.8%	-207.0%	-236.9%	-175.3%	-169.0%	-122.7%
Non-recurring items [+]	2.0	24.5		-5.4	-1.1	1.5
Unusual expense		12.3				1.1
Loss on contingent liability	2.0	12.3		-5.4	-1.1
Interest expense	3.6	3.6		3.7	3.7	3.5
Interest expense	3.6	3.6	3.7	3.7	3.7	3.5	3.7	3.6
Other income (expense), net [+]	6.9	6.9	-14.3	0.3	-0.3	-1.2	-15.7	0.2
Gain (loss) on debt retirement	-2.0
Other	8.9	6.9		0.3	-0.3	0.0
Pre-tax income	-69.8	-88.0	-77.0	-71.4	-81.5	-69.3	-78.3	-41.0
Income taxes	0.0	0.0	0.0	0.0	0.0	0.0	-94.8	0.0
Tax rate	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	121.1%	0.0%
Net income	-69.8	-88.0	-77.0	-71.4	-81.5	-69.3	16.5	-41.0
Net margin	-146.8%	-226.3%	-238.2%	-201.3%	-245.7%	-192.5%	47.4%	-133.9%

Basic EPS [+]	($0.28)	($0.36)	($0.34)	($0.32)	($0.37)	($0.31)	$0.08	($0.21)
Growth	-12.2%	-0.8%	-517.9%	54.0%	-18.3%	-169.2%	-157.6%	37.9%
Diluted EPS [+]	($0.28)	($0.36)	($0.34)	($0.32)	($0.37)	($0.31)	$0.08	($0.21)
Growth	-12.2%	-0.8%	-544.6%	54.0%	-18.3%	-173.3%	-154.1%	37.9%

Shares outstanding (basic) [+]	250.1	242.0	225.1	224.5	222.3	220.7	202.2	198.6
Growth	11.4%	8.9%	11.3%	13.1%	14.1%	33.6%	21.2%	28.8%
Shares outstanding (diluted) [+]	250.1	242.0	225.1	224.5	222.3	220.7	215.1	198.6
Growth	11.4%	8.9%	4.6%	13.1%	14.1%	26.2%	28.9%	28.8%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.